GSK Relvar Ellipta

Relvar Ellipta is a prescription inhalation powder containing fluticasone furoate and vilanterol, formulated for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD). The Ellipta dry powder inhaler device delivers measured doses directly to the lungs.

The medication and its proprietary inhaler device were developed by GlaxoSmithKline (GSK) in collaboration with Innoviva (formerly Theravance). GSK is a British multinational pharmaceutical and biotechnology company headquartered in London, United Kingdom. Ellipta devices and respiratory products are primarily manufactured at GSK's specialized manufacturing and packaging facilities in the United Kingdom (such as Ware, Hertfordshire), with distribution managed through GSK's regional European operating entities.